Brief: N4 Pharma PLC Appointes David H Solomon As CEO
Feb 24 (Reuters) - N4 Pharma PLC N4P.L: N4 PHARMA PLC - CEO APPOINTMENT & NAME CHANGE THALIA THERAPEUTICS N4 PHARMA PLC - DAVID H SOLOMON APPOINTED AS CEO N4 PHARMA PLC - NIGEL THEOBALD STEPS DOWN AS CEO N4 PHARMA PLC - TO BE RENAMED THALIA THERAPEUTICS Source text: ID:nRSX0705Ua Further company coverage: N4P.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results